Jane Street’s Albany Molecular Research Inc AMRI Stock Holding History

Jane Street’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,055	Closed	-$310K	–	4838
2016 Q2	$310K	Buy	+23,055	New	+$336K	﹤0.01%	3285
2015 Q1	–	Sell	-18,324	Closed	-$298K	–	3683
2014 Q4	$298K	Buy	+18,324	New	+$336K	﹤0.01%	1890
2014 Q3	–	Sell	-20,204	Closed	-$407K	–	3369
2014 Q2	$407K	Buy	+20,204	New	+$342K	0.01%	1575
2014 Q1	–	Sell	-12,334	Closed	-$124K	–	3286
2013 Q4	$124K	Buy	+12,334	New	+$149K	﹤0.01%	2147
2013 Q3	–	Sell	-55,418	Closed	-$658K	–	3362
2013 Q2	$658K	Buy	+55,418	New	+$600K	0.01%	1213

Other funds holding AMRI

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Jane Street's AMRI Position: Q3 2016 in Review

Jane Street sold out of Albany Molecular Research Inc (AMRI) in Q3 2016, closing a stake of 23,055 shares — an estimated $310K sold.

Jane Street first reported a position in AMRI in Q2 2013 and held it in 5 quarters. The position peaked at $658K in Q2 2013. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

Jane Street reported no remaining Albany Molecular Research Inc position as of Q3 2016 after selling out during the quarter.
Jane Street sold 23,055 Albany Molecular Research Inc shares in Q3 2016, an estimated $310K.
Jane Street first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 5 quarters.
Jane Street's Albany Molecular Research Inc position peaked at $658K in Q2 2013.
137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.